Eucalyptus
Overview
Eucalyptus is an Australian digital healthcare company that operates a suite of telehealth clinics, including Pilot (Men's Health), Kin (Fertility), Software (Dermatology), and Juniper (Weight Loss and Menopause). Founded in 2019, the company aims to provide high-quality, patient-centered healthcare through its technology-driven platform. Eucalyptus has facilitated over one million consultations across Australia, the UK, and Germany, offering services that range from reproductive healthcare to chronic care management. The company's investment strategy focuses on early-stage technology companies, particularly those in the healthcare sector. Eucalyptus has secured significant funding from prominent venture capital firms, including a $30 million AUD Series B round led by NewView Capital in 2021. This funding has enabled the company to expand its services and develop new healthcare modules, such as behavioral health and chronic care. Eucalyptus's portfolio companies include Pilot, Kin, Software, and Juniper, each targeting specific healthcare needs with tailored digital solutions. Eucalyptus's approach combines clinical expertise with technological innovation to deliver accessible and effective healthcare solutions. The company's mission is to build deep, seamless models of care that put the patient first, leveraging technology to overcome the hurdles of the traditional healthcare system. Eucalyptus's commitment to patient safety and clinical governance is evident in its robust safety audit functions and incident management processes, ensuring high-quality care across its digital clinics.
Investment Focus
- Early-stage technology companies
- Healthcare sector focus
- Scalable business models
- Strong management teams
- Innovative solutions addressing healthcare challenges
Portfolio Companies
Reach Eucalyptus directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Eucalyptus
What sectors does Eucalyptus invest in?
Eucalyptus invests in Technology, Healthcare, Digital Health, Pharmaceuticals, Women's Health and Fertility, and is based in Dawes Point, Australia. Eucalyptus is listed as a venture capital in the ConnectSafely investor database.
What stage does Eucalyptus invest at?
Eucalyptus backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 10M - 50M.
Which regions does Eucalyptus invest in?
Eucalyptus invests across United Kingdom, Germany and Australia.
Who are the partners at Eucalyptus?
Team members listed for Eucalyptus include Sebastian Urban (Chief Technology Officer) and Simon Baume (Chief Operating Officer).
What companies has Eucalyptus invested in?
Eucalyptus's portfolio includes Kin, Pilot, Software and Juniper.
How do I contact Eucalyptus?
Eucalyptus's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
